Celltrion Inc
KRX:068270

Watchlist Manager
Celltrion Inc Logo
Celltrion Inc
KRX:068270
Watchlist
Price: 186 100 KRW 0.81% Market Closed
Market Cap: 40.4T KRW

Celltrion Inc's latest stock split occurred on Dec 27, 2024

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Celltrion Inc traded at 191500.0008 per share. Afterward, the share price was about 180400.

The adjusted shares began trading on Dec 27, 2024. This was Celltrion Inc's 17th stock split, following the previous one in Dec 28, 2022.

Last Splits:
Dec 27, 2024
1-for-1
Dec 28, 2022
1-for-1
Dec 29, 2021
1-for-1
Dec 29, 2020
1-for-1
Dec 27, 2019
1-for-1
Pre-Split Price
181 630.9531 191 500.0008
Post-Split Price
180 400
Before
After
Last Splits:
Dec 27, 2024
1-for-1
Dec 28, 2022
1-for-1
Dec 29, 2021
1-for-1
Dec 29, 2020
1-for-1
Dec 27, 2019
1-for-1

Celltrion Inc
Stock Splits History

Celltrion Inc Stock Splits Timeline
Dec 27, 2024
Dec 27, 2024
Split 1-for-1
/1
Pre-Split Price
181 630.9531 191 500.0008
Post-Split Price
180 400
Before
After
Dec 28, 2022
Dec 28, 2022
Split 1-for-1
/1
Pre-Split Price
160 600.0698 176 999.9937
Post-Split Price
156 534.3825
Before
After
Dec 29, 2021
Dec 29, 2021
Split 1-for-1
/1
Pre-Split Price
191 429.1208 215 999.9949
Post-Split Price
182 376.3603
Before
After
Dec 29, 2020
Dec 29, 2020
Split 1-for-1
/1
Pre-Split Price
289 767.6589 333 499.9859
Post-Split Price
319 491.656
Before
After
Dec 27, 2019
Dec 27, 2019
Split 1-for-1
/1
Pre-Split Price
156 810.085 189 499.9926
Post-Split Price
159 871.8113
Before
After
Dec 27, 2018
Dec 27, 2018
Split 1-for-1
/1
Pre-Split Price
184 969.2244 228 000.0038
Post-Split Price
184 531.1365
Before
After
Dec 27, 2017
Dec 27, 2017
Split 1-for-1
/1
Pre-Split Price
155 095.4448 194 999.9919
Post-Split Price
178 479.0663
Before
After
Dec 28, 2016
Dec 28, 2016
Split 1-for-1
/1
Pre-Split Price
80 520.861 106 299.9987
Post-Split Price
84 705.979
Before
After
Dec 29, 2015
Dec 29, 2015
Split 1-for-1
/1
Pre-Split Price
56 407.0364 76 699.9988
Post-Split Price
63 628.9016
Before
After
Dec 29, 2014
Dec 29, 2014
Split 1-for-1
/1
Pre-Split Price
27 630.9388 39 450.0008
Post-Split Price
28 497.6887
Before
After
Dec 27, 2013
Dec 27, 2013
Split 1-for-1
/1
Pre-Split Price
25 874.1487 38 050.0005
Post-Split Price
26 755.4338
Before
After
Mar 22, 2013
Mar 22, 2013
Split 1-for-2
/0.5
Pre-Split Price
36 516.2075 53 699.9974
Post-Split Price
37 740.2177
Before
After
Mar 4, 2013
Mar 4, 2013
Split 1-for-2
/0.5
Pre-Split Price
36 516.2075 26 849.9986
Post-Split Price
36 516.2075
Before
After
Dec 27, 2012
Dec 27, 2012
Split 1-for-1
/1
Pre-Split Price
33 804.3812 28 600.0004
Post-Split Price
35 360.2016
Before
After
May 24, 2012
May 24, 2012
Split 1-for-1
/1
Pre-Split Price
32 780.0067 41 600.0008
Post-Split Price
33 095.198
Before
After
Sep 28, 2006
Sep 28, 2006
Split 1655-for-1478
x1.1197564276049
Pre-Split Price
3 715.3579 4 880.0003
Post-Split Price
3 426.0473
Before
After
Aug 21, 2006
Aug 21, 2006
Split 679-for-617
x1.1004862236629
Pre-Split Price
3 997.0551 5 250.0001
Post-Split Price
3 601.1562
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Mar 11, 2025
D
Daiwa Heavy Industry Co Ltd
TSE:5610
1-for-145346
/145346
999999.9999 999999.9999 JPY N/A
Mar 10, 2025
SBC Exports Ltd
NSE:SBC
3-for-2
x1.5
20.655 13.77 INR 14.05 14.05 INR
Mar 10, 2025
E
ELEVAI Labs Inc
NASDAQ:ELAB
1-for-7
/7
0.72 5.04 USD 5.1601 5.1601 USD
Mar 10, 2025
I
Indigo Exploration Inc
XTSX:IXI
1-for-2
/2
0.035 0.07 CAD 0.07 0.07 CAD
Mar 10, 2025
I-PEX Inc
TSE:6640
1-for-1831275
/1831275
999999.9999 999999.9999 JPY N/A
Load More

Celltrion Inc
Glance View

Market Cap
40.3T KRW
Industry
Biotechnology

Celltrion Inc. stands as a significant player in the global biopharmaceutical industry, rooted in the heart of South Korea's bustling innovation scene. Founded in 2002 by Seo Jung-Jin, the company initially carved its niche in the development of biosimilars, which are near-identical versions of original biological drugs whose patents have expired. With rapid advancements in biotechnology, Celltrion has well-positioned itself to tap into the expanding market for affordable and accessible biologic treatments. At the core of its operation is its cutting-edge production facilities equipped with high-tech fermentation and purification processes necessary for manufacturing these complex medicines. This foundational expertise has allowed Celltrion to pioneer some of the world's first monoclonal antibody biosimilars, including those for autoimmune diseases and oncological conditions, thereby cementing its reputation as a forerunner in global biosimilar development. The company’s revenue model is intricately tied to its production capabilities and strategic partnerships. By leveraging its advanced manufacturing infrastructure, Celltrion not only produces its own line of biosimilars but also collaborates with global pharmaceutical companies to license and distribute its products worldwide. Such partnerships have enabled Celltrion to penetrate markets across Europe, the Americas, and Asia, with its biosimilars gaining regulatory approval in many regions. Furthermore, Celltrion’s business is not limited to biosimilars; it is actively investing in novel biologics and innovative delivery systems. This diversification strategy underscores its commitment to sustainable growth and reducing dependence on any single product line, ultimately fostering a robust pipeline that promises to meet the healthcare industry's evolving demands.

Intrinsic Value
181 903.28 KRW
Overvaluation 2%
Intrinsic Value
Price
Back to Top